JPRN-UMIN000028465已完成未知
Direct hemoperfusion of protein-bound uremic toxins - Protein-bound uremic toxin adsorption from blood
Division of Blood Purification Therapy, Niigata University Medical and Dental Hospital0 个研究点目标入组 10 人开始时间: 2017年7月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who treat infection. Pregnancy. Duration of dialysis treatment less than 1 year.
研究者
相似试验
尚未招募
不适用
A clinical trial to Compare effects of purified protein derivative injection with liquid nitrogen spray for treatment of viralwartsCTRI/2015/03/005614StJOHN S medical college70
进行中（未招募）
1 期
Injections intradétrusoriennes de toxine botulique A chez l'enfant présentant un syndrome d'hyperactivité vésicale neurogène : essai thérapeutique contrôlé multicentrique de non infériorité entre deux doses rapportées au poids. - TBIDESyndrome d'hyperactivité vésicale neurogène chez l'enfantMedDRA version: 12.1Level: LLTClassification code 10029279Term: Neurogenic bladderEUCTR2010-021265-80-FRCentre Hospitalier Universitaire de Reims
招募中
不适用
Hemoperfusion for organophosphate poisoning in critically ill patients- A randomized trial.Injury, Occupational Diseases, PoisoningPACTR202009754904918Jalo40
已完成
4 期
Protein-bound uremic toxin lowering effects of sevelamer in end-stage kidney disease receiving hemodialysis with hyperphosphatemia: a randomized controlled trialProtein-bound uremic toxinEnd stage kidney disease receiving hemodialysisSevelamerCalcium carbonatePhosphate binderProtein-bound uremic toxinp-cresyl sulfateIndoxyl sulfateCardio-ankle vascular index (CAVI)End stage renal diseaseHemodialysisTCTR20230530004Faculty of medicine, CHulalongkorn university140
进行中（未招募）
1 期
Intravesikal instillation af Botulinum toxin type A til patienter med urge urininkontinensEUCTR2008-006526-34-DKGynækologisk-obstetrisk afd. G, Glostrup Hospital20